Dental Bone Graft Substitute Market Size, Share & COVID19 Impact Analysis | United States | 2023-2029 | MedSuite | Includes: Dental Bone Graft Substitutes, Dental Barrier Membranes, and 3 more
The U.S. dental bone graft substitute and other biomaterials market had a value of $589 million in 2022 and is projected to grow at a CAGR of 5.3% during the forecast period, reaching a value of over $847 million. The comprehensive report suite on the U.S. dental bone graft substitutes market comprises several segments, including dental bone graft substitutes, dental growth factors, dental barrier membranes, local antimicrobial periodontal treatments, and dental soft tissue regeneration, all of which together form the dental biomaterials market.
DATA TYPES INCLUDED IN THIS REPORT
Unit Sales, Average Selling Prices, Market Value & Growth Trends
Market Forecasts Until 2029 & Historical Data to 2019
Competitive Analysis with Market Shares for Each Market Segment
Market Drivers & Limiters
Recent Mergers & Acquisitions
COVID19 Impact on the DBGS Market in the US
Disease Overviews & Demographic Information
Company Profiles, Product Portfolios & SWOT for Top Competitors
U.S. DENTAL BONE GRAFT SUBSTITUTE MARKET TRENDS
The dental bone graft substitute market is closely linked to the growth of the dental implant and final abutment markets, with over half of dental implant procedures requiring bone grafting beforehand. The U.S. dental implant market is expected to see significant growth over the forecast period, which will in turn drive demand for dental bone graft substitutes. As the dental implant market continues to expand, so too will the demand for dental bone graft substitutes.
U.S. DENTAL BONE GRAFT SUBSTITUTE MARKET SHARE INSIGHTS
The dental bone graft substitute market in the U.S. is largely controlled by four main competitors: Geistlich, ZimVie, OraPharma and BioHorizons. The remainder of the market is made up of smaller competitors and various tissue banks that distribute primarily through various companies in the market.
Geistlich emerged as the leading player in the dental bone graft substitute and other biomaterials market, with significant market shares in the dental bone graft substitute, dental barrier membrane, and dental soft tissue regeneration segments. The company's focus on regenerating bone, cartilage, and tissue has given it a competitive edge in the market. In October 2022, Geistlich further solidified its position by acquiring Lynch Biologics and obtaining the rights to its GEM 21S® dental growth factor product. With only four dental growth factor products available in the U.S. market, this acquisition sets Geistlich apart and strengthens its presence in the dental bone graft substitute market.
MARKET SEGMENTATION SUMMARY
Dental Bone Graft Substitute Market | United States | 2023-2029 – Includes:
Allograft, xenograft and synthetic material sub-segments.
Dental Barrier Membrane Market | United States | 2023-2029 – Includes:T
Resorbable and non-resorbable dental barrier membrane segments.
Dental Growth Factor Market | United States | 2023-2029 – Includes:
Straumann’s Emdogain®, Lynch Biologics’ GEM 21S®, Medtronic’s Infuse® and NuVasive’s Osteocel® (distributed by ACE SOUTHERN).
Local Antimicrobial Periodontal Treatment Market | United States | 2023-2029
Dental Soft Tissue Regeneration Market | United States | 2023-2029 – Includes:
Dental soft tissue regeneration market and dental soft tissue wound care market segments.
RESEARCH SCOPE SUMMARY
Regions
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook